TY  - GEN
AU  - Langer,Corey J
AU  - Gadgeel,Shirish M
AU  - Borghaei,Hossein
AU  - Papadimitrakopoulou,Vassiliki A
AU  - Patnaik,Amita
AU  - Powell,Steven F
AU  - Gentzler,Ryan D
AU  - Martins,Renato G
AU  - Stevenson,James P
AU  - Jalal,Shadia I
AU  - Panwalkar,Amit
AU  - Yang,James Chih-Hsin
AU  - Gubens,Matthew
AU  - Sequist,Lecia V
AU  - Awad,Mark M
AU  - Fiore,Joseph
AU  - Ge,Yang
AU  - Raftopoulos,Harry
AU  - Gandhi,Leena
TI  - Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study
SN  - 1474-5488
PY  - 2017///0526
KW  - Aged
KW  - Antibodies, Monoclonal, Humanized
KW  - administration & dosage
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Carboplatin
KW  - Carcinoma, Non-Small-Cell Lung
KW  - drug therapy
KW  - Female
KW  - Humans
KW  - Lung Neoplasms
KW  - Male
KW  - Middle Aged
KW  - Pemetrexed
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial
UR  - https://doi.org/10.1016/S1470-2045(16)30498-3
ER  -